Clinical trial
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
NCT00230451 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00230451 |
|---|---|
| Title | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma |
| Official title | A Phase II Trial of Preoperative Chemotherapy and Radiation Therapy Followed by Adjuvant Combination Chemotherapy for Patients With Loco-Regional Esophageal Carcinoma |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Radiation, Paclitaxel, Cisplatin, 5-Fluorouracil |
| Start date | Nov 1, 1997 |
| Primary completion | Dec 1, 1999 |
| Completion | Jul 1, 2008 |
| First posted | Sep 30, 2005 |
| Last update posted | Jan 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: